ALPS Advisors »

Inhibikase Therapeutics shares owned by ALPS Advisors

Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by ALPS Advisors from 13F filings

Historical chart of ALPS Advisors investment in Inhibikase Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Inhibikase Therapeutics held by ALPS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibikase Therapeutics by ALPS Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $272k 134k 2.03

More positions owned by ALPS Advisors

Energy Transfer Com Ut Ltd Ptn (ET)
Sunoco Lp/sunoco Fin Corp Com Ut Rep Lp (SUN)
MPLX Com Unit Rep Ltd (MPLX)
Enterprise Products Partners (EPD)
Western Midstream Partners L Com Unit Lp Int (WES)
Plains All Amern Pipeline L Unit Ltd Partn (PAA)
Hess Midstream Cl A Shs (HESM)
Cheniere Energy Partners Com Unit (CQP)
Usa Compression Partners Com Unit Ltdpar (USAC)
Cameco Corporation (CCJ)
Genesis Energy Unit Ltd Partn (GEL)
Waterbridge Infrastructure L Cl A Shs Repstg (WBI)
Global Partners Com Units (GLP)
Suburban Propane Partners L Unit Ltd Partn (SPH)
Nexgen Energy (NXE)

View all positions for ALPS Advisors

Top funds holding Inhibikase Therapeutics

Sands Capital Ventures
Soleus Capital Management
Trails Edge Capital Partners
Fairmount Funds Management
BlackRock
ADAR1 Capital Management
Blackstone Group
Siren
Commodore Capital
Vanguard Capital Management
Millennium Management
Saturn V Capital Management
Kalehua Capital Management
Spruce Street Capital
Squadron Capital Management

View all funds holding Inhibikase Therapeutics